
Enlivex Therapeutics Ltd.
ENLVHealthcare|Biotechnology|IL
$1.27
+0.00 (+0.00%)
Tangible Book / Share
$2661.47
Graham Number
$18359.01
Cash / Share
$5.34
Ownership Breakdown
99.5%
Float
16.8M
Shares Outstanding
16.7M
Float Shares
Major Holders (5)
Combined: 40.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Lind Partners LLC | Other | 9.99% | 1,927,744 | Aug 13, 2026 | 13D/G |
| Easton Jeff | Individual | 9.99% | 1,927,744 | Aug 13, 2026 | 13D/G |
| Lind Global Asset Management XIV, LLC | Other | 9.99% | 1,927,744 | Aug 13, 2026 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 209,340 | Aug 14, 2025 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 209,340 | Aug 14, 2025 | 13D/G |
Insider Trades (29)
Last 4 quarters: 0 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Hershkovitz Oren | Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hershkovitz Oren | Chief Executive Officer | Nov 16, 2023 | OTHER | 150,000 | $8.19 | $1.2M | Form 4 |
| Hershkovitz Oren | Chief Executive Officer | Nov 24, 2025 | OTHER | 60,000 | $5.34 | $320.4K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Mar 7, 2021 | OTHER | 1,452 | $2.69 | $3.9K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Dec 12, 2021 | OTHER | 1,452 | $6.22 | $9.0K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Mar 30, 2024 | OTHER | 5,000 | $4.68 | $23.4K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Dec 10, 2022 | OTHER | 1,452 | $10.12 | $14.7K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Nov 24, 2025 | OTHER | 10,000 | $3.21 | $32.1K | Form 4 |
| Shlosberger Shachar | Chief Financial Officer | Nov 24, 2025 | OTHER | 7,500 | $5.34 | $40.0K | Form 4 |
| Hart Gili | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hart Gili | director | Jun 1, 2019 | OTHER | 66,489 | $2.69 | $178.9K | Form 4 |
| Hart Gili | director | Mar 18, 2026 | OTHER | 3,382 | $5.34 | $18.1K | Form 4 |
| NOVIK SHAI A | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| NOVIK SHAI A | director | Dec 12, 2021 | OTHER | 145,237 | $6.22 | $903.4K | Form 4 |
| NOVIK SHAI A | director | May 3, 2023 | OTHER | 250,000 | $3.66 | $915.0K | Form 4 |
| NOVIK SHAI A | director | May 28, 2024 | OTHER | 250,000 | $12.23 | $3.1M | Form 4 |
| NOVIK SHAI A | director | Nov 17, 2025 | OTHER | 250,000 | $5.34 | $1.3M | Form 4 |
| NOVIK SHAI A | director | Jun 1, 2019 | OTHER | 132,979 | $2.69 | $357.7K | Form 4 |
| Pomerantz Roger | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Pomerantz Roger | director | Mar 18, 2026 | OTHER | 150,000 | $5.97 | $895.0K | Form 4 |
| Havron Avraham | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Havron Avraham | director | Jun 1, 2019 | OTHER | 53,192 | $2.69 | $143.1K | Form 4 |
| Havron Avraham | director | Mar 18, 2026 | OTHER | 3,382 | $5.34 | $18.1K | Form 4 |
| Galamidi Einat | Chief Medical Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Galamidi Einat | Chief Medical Officer | Nov 24, 2025 | OTHER | 25,000 | $5.34 | $133.5K | Form 4 |
| Galamidi Einat | Chief Medical Officer | Nov 24, 2025 | OTHER | 10,000 | $3.21 | $32.1K | Form 4 |
| WEATHERSON HARVEY D | director | Jan 2, 2008 | AWARD | 12,000 | $1.25 | $15.0K | Form 4 |
| RANEY DENNIS R | director | Jan 2, 2008 | AWARD | 12,000 | $1.25 | $15.0K | Form 4 |